[Contact allergy to eyedrops containing beta-blockers]
- PMID: 9623207
[Contact allergy to eyedrops containing beta-blockers]
Abstract
In six patients (4 women aged 80, 62, 43 and 52 years and 2 men aged 58 and 51 years), who used eyedrops containing beta-blockers for the treatment of glaucoma, allergic contact dermatitis of the eyelids was diagnosed. Three were allergic to metipranolol, 2 to levobunolol and 1 to timolol. In literature, less than 50 cases of hypersensitivity to beta-blockers in eye medication have been reported. There are, however, reasons to assume that sensitization is more frequent: (a) not all patients are referred by the ophthalmologist to the dermatologist; (b) false-negative reactions to patch tests with the commercial preparations and with beta-blockers are not infrequent; (c) they are not routinely tested because beta-blockers are difficult to obtain in pure form; (d) cross-reactions with other beta-blockers are infrequent, and changing to another preparation therefore usually solves the clinical problem. Nevertheless it is advisable to test a battery of beta-blockers (befunolol, levobunolol, metipranolol, timolol) in allergic patients. A test preparation of 2% in water or 3%-10% in petrolatum may be suitable. Control testing in non-exposed individuals is necessary to exclude irritation reactions.
Similar articles
-
Contact dermatitis to topical drugs for glaucoma.Am J Contact Dermat. 2001 Dec;12(4):217-9. doi: 10.1053/ajcd.2001.25129. Am J Contact Dermat. 2001. PMID: 11753897 Review.
-
Allergic contact dermatitis from carteolol and timolol in eyedrops.Contact Dermatitis. 2000 Apr;42(4):245. Contact Dermatitis. 2000. PMID: 10750865 No abstract available.
-
Allergic contact dermatitis due to beta-blockers in eye drops: a retrospective analysis of multicentre surveillance data 1993-2004.Acta Derm Venereol. 2006;86(6):509-14. doi: 10.2340/00015555-0162. Acta Derm Venereol. 2006. PMID: 17106597
-
[Contact allergy to beta blockaders in eye drops: cross allergy?].Ann Dermatol Venereol. 1997;124(4):322-4. Ann Dermatol Venereol. 1997. PMID: 9739938 French.
-
[Adverse effects of local use of beta-blockaders in glaucoma. A literature review and a survey of reports to the adverse drug reaction authority 1986-95].Tidsskr Nor Laegeforen. 1997 May 30;117(14):2019-21. Tidsskr Nor Laegeforen. 1997. PMID: 9235677 Review. Norwegian.
Cited by
-
Risk factors for periorbital dermatitis in patients using dorzolamide/timolol eye drops.Sci Rep. 2021 Sep 9;11(1):17896. doi: 10.1038/s41598-021-97565-0. Sci Rep. 2021. PMID: 34504268 Free PMC article.
-
Eyelid dermatitis in patch-tested adult patients: a systematic review with a meta-analysis.Sci Rep. 2024 Aug 13;14(1):18791. doi: 10.1038/s41598-024-69612-z. Sci Rep. 2024. PMID: 39138344 Free PMC article.
-
Periorbital dermatitis as a side effect of topical dorzolamide.Br J Ophthalmol. 2002 Apr;86(4):378-80. doi: 10.1136/bjo.86.4.378. Br J Ophthalmol. 2002. PMID: 11914202 Free PMC article.
-
Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue.Drugs Aging. 2011 Apr 1;28(4):267-82. doi: 10.2165/11588830-000000000-00000. Drugs Aging. 2011. PMID: 21428462 Review.
-
Beta-adrenergic antagonist for the healing of chronic diabetic foot ulcers: study protocol for a prospective, randomized, double-blinded, controlled and parallel-group study.Trials. 2020 Jun 8;21(1):496. doi: 10.1186/s13063-020-04413-z. Trials. 2020. PMID: 32513257 Free PMC article.